ZBIO
Zenas BioPharma, Inc.
NASDAQ · USHealthcareBiotechnology
$30.70+3.96%
Price as of Jul 20, 2026
ZBIO capital
Zenas BioPharma, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 1.05x
- Net debt / equity
- -0.44x
- Debt / assets
- 0.47x
- Debt / EBITDA
- -0.86x
- Net debt / EBITDA
- 0.36x
Liquidity & coverage
- Current ratio
- 11.94x
- Quick ratio
- 11.94x
- Cash ratio
- 11.73x
- Interest coverage
- -63.80x
- EBITDA / interest
- -61.59x
- Working capital
- $669.0M
Cash & dividend
- FCF / debt
- -0.60x
- Cash flow / debt
- -0.60x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.